Scientists hunt for new clues in breast cancer blood tests
NCT ID NCT05817227
Summary
This study aims to understand whether certain proteins called selenoproteins could serve as markers for breast cancer progression or as targets for future treatments. Researchers will analyze tissue samples from past patients and collect blood samples from 300 breast cancer patients and 100 healthy women. The goal is to gather knowledge that could lead to better ways to predict outcomes or develop new therapies for triple-negative breast cancer.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Istituto Nazionale Tumori - Fondazione "G.Pascale", IRCCS
RECRUITINGNapoli, Napoli, 80131, Italy
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Istituto Nazionale Tumori Regina Elena
RECRUITINGRoma, Roma, 00144, Italy
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.